日本黄色小说视频,日韩在线一区二区三区免费视频,亚洲电影在线,精品欧美日韩一区二区三区,久久香蕉国产线看观看亚洲卡,美女浴室,美女脱衣诱惑

資訊|論壇|病例

搜索

首頁 醫(yī)學論壇 專業(yè)文章 醫(yī)學進展 簽約作者 病例中心 快問診所 愛醫(yī)培訓 醫(yī)學考試 在線題庫 醫(yī)學會議

您所在的位置:首頁 > 心血管內科診療指南 > 2008美國先天性心臟病指南

2008美國先天性心臟病指南

2014-06-04 17:26 閱讀:3008 來源:愛愛醫(yī) 責任編輯:張子玲
[導讀] It is important that the medical profession play a central rolein critically evaluating the use of diagnostic procedures andtherapies introduced and tested for detection, management, orprevention of disease.

    《2008美國先天性心臟病指南》內容簡介:

    It is important that the medical profession play a central rolein critically evaluating the use of diagnostic procedures andtherapies introduced and tested for detection, management, orprevention of disease. Rigorous, expert **ysis of the avail-able data documenting absolute and relative benefits and risksof these procedures and therapies can produce guidelines thatimprove the effectiveness of care, optimize patient outcomes,and favorably affect the cost of care by focusing resources onthe most effective strategies.

    《2008美國先天性心臟病指南》內容預覽:

   
The American College of Cardiology Foundation (ACCF)and the American Heart Association (AHA) have jointlyengaged in the production of guidelines in the area ofcardiovascular disease since 1980. The American College ofCardiology (ACC)/AHA Task Force on Practice Guidelinesis charged with developing, updating, and revising practiceguidelines for cardiovascular diseases and procedures anddirects this effort. Writing committees are charged withassessing the evidence as an independent group of authors todevelop, update, or revise recommendations for clinicalpractice.

    Experts in the subject under consideration have beenselected from both organizations to examine subject-specificdata and write guidelines in partnership with representativesfrom other medical practitioner and specialty groups. Writingcommittees are specifically charged to perform a formalliterature review, weigh the strength of evidence for oragainst particular treatments or procedures, and includeestimates of expected health outcomes where data exist.Patient-specific modifiers, comorbidities, and issues of pa-tient preference that might influence the choice of tests ortherapies are considered, as well as the frequency offollow-up and cost-effectiveness. When available, ***rma-tion from studies on cost is considered, but data on efficacyand clinical outcomes constitute the primary basis for recom-mendations in these guidelines.

    點擊下載***:《2008美國先天性心臟病指南》


分享到:
  版權聲明:

  本站所注明來源為"愛愛醫(yī)"的文章,版權歸作者與本站共同所有,非經授權不得轉載。

  本站所有轉載文章系出于傳遞更多信息之目的,且明確注明來源和作者,不希望被轉載的媒體或個人可與我們

  聯(lián)系zlzs@120.net,我們將立即進行刪除處理

意見反饋 關于我們 隱私保護 版權聲明 友情鏈接 聯(lián)系我們

Copyright 2002-2024 Iiyi.Com All Rights Reserved